United Capital Financial Advisers, LLC Atri Cure, Inc. Transaction History

United Capital Financial Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $480,406 - $649,127	-19,967 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $1,500 - $2,048	-63 Reduced 0.31%	19,967 $498,000
Q2 2019 Aug 13, 2019	BUY	$26.85 - $30.74 $751 - $860	28 Added 0.14%	20,030 $598,000
Q1 2019 May 14, 2019	SELL	$26.38 - $33.34 $52 - $66	-2 Reduced 0.01%	20,002 $536,000
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $114,068 - $175,775	5,805 Added 40.88%	20,004 $541,000
Q4 2017 Feb 13, 2018	SELL	$17.69 - $23.44 $796 - $1,054	-45 Reduced 0.32%	14,199 $259,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,244	14,244 $345,000

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.78B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.